The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 13, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 7
- 0 vs. Q3 2022
- Portfolio value
- $300.4M
- −$151.4M (−33.5%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 4,577,840 | $109.0M | 36.3% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $91.0M | 30.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $53.1M | 17.7% | +1630.0% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $21.0M | 7.0% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $18.9M | 6.3% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,414,795 | $5.48M | 1.8% | +166,666+1.8% | Added | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $1.84M | 0.6% | 00.0% | Unchanged | History |